The effect of adenosine transport inhibition on cardiovascular function and survival after severe asphyxia in fetal lambs.
When the energy demand exceeds the energy supply, anaerobic metabolism takes over and the ATP catabolite adenosine is generated. Adenosine acts as a coronary vasodilator, thereby increasing the oxygen supply to the heart. Its potential, however, is poorly exploited due to extensive catabolism. R-75231 inhibits transport of adenosine into endothelial cells, where it is catabolized, resulting in an elevation of interstitial adenosine concentrations. In 14 fetal lambs (3 to 5 d after surgery, gestational age 124.1 +/- 1.1 d), seven fetuses were pretreated with R-75231 (0.1 mg/kg estimated fetal weight as a bolus injection in the inferior vena cava), whereas the other seven served as controls. After 1 h of severe asphyxia, induced by restriction of uterine blood flow, those fetuses treated with R-75231 showed a faster normalization of aortal pH and, in contrast to the control group, did not develop tachycardia. The percentage increase in myocardial blood flow during asphyxia, measured with radioactive microspheres, was significantly higher in the R-75231-treated group compared with the control group (437 and 284%, respectively). In the control group, only three fetuses recovered and survived, whereas in the R-75231 group, all seven animals recovered after severe asphyxia. It is concluded that fetal lambs pretreated with R-75231 before the onset of severe asphyxia have an enhanced increase in myocardial blood flow during asphyxia, recover faster, and survive longer.
de Haan
H H
HH
Department of Obstetrics and Gynecology, University Hospital, Maastricht, The Netherlands.
de Haan
J
J
Van Reempts
J L
JL
Van Belle
H
H
Hasaart
T H
TH
D000241:Adenosine / Q000378:metabolism*; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects / Q000503:physiopathology*; D003326:Coronary Circulation / Q000187:drug effects; D005260:Female; D005311:Fetal Hypoxia / Q000188:drug therapy / Q000503:physiopathology*; D006340:Heart Rate, Fetal / Q000187:drug effects; D010100:Oxygen / Q000097:blood; D010879:Piperazines / Q000494:pharmacology; D011247:Pregnancy; D012756:Sheep
D010879:Piperazines; C072040:draflazine; D000241:Adenosine; D010100:Oxygen